CLINICAL_TRIALS
trial_result
· 2017-01-18
Clinical Trial Update: Ranolazine for the Treatment of Chest Pain in HCM Patients [Phase 4]
Summary
Phase 4 clinical trial evaluating ranolazine for chest pain in patients with hypertrophic cardiomyopathy, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Hypertrophic Cardiomyopathy | Phase 4 | Status: COMPLETED | Results posted: 2017-01-18